Gabapentin Treatment of Cannabis Dependence

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA); The Scripps Research Institute
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

• Males or females age 18-65 with cannabis dependence

• Meets DSM-IV-TR criteria for Cannabis Dependence

• Smoked marijuana at least once a week in the 90 days prior to study participation

• Willing to attend 12 weekly study visits and 1 follow-up visit

Exclusion Criteria:

• Currently meets DSM-IV-TR criteria for dependence on illicit substances other than cannabis

• Significant medical disorders that will increase potential risk or interfere with study participation

• Women with childbearing potential who are pregnant, nursing, or refuse to use a reliable method of birth control

• Treatment with an investigational drug in the last month